BR112014018530A8 - Composições e métodos para aprimorar a lactação - Google Patents

Composições e métodos para aprimorar a lactação

Info

Publication number
BR112014018530A8
BR112014018530A8 BR112014018530A BR112014018530A BR112014018530A8 BR 112014018530 A8 BR112014018530 A8 BR 112014018530A8 BR 112014018530 A BR112014018530 A BR 112014018530A BR 112014018530 A BR112014018530 A BR 112014018530A BR 112014018530 A8 BR112014018530 A8 BR 112014018530A8
Authority
BR
Brazil
Prior art keywords
serotonin
compositions
methods
lactation
agents
Prior art date
Application number
BR112014018530A
Other languages
English (en)
Other versions
BR112014018530A2 (pt
Inventor
Horseman Nelson
Hernandez Baumgard Laura
Original Assignee
Univ Cincinnati
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cincinnati, Wisconsin Alumni Res Found filed Critical Univ Cincinnati
Publication of BR112014018530A2 publication Critical patent/BR112014018530A2/pt
Publication of BR112014018530A8 publication Critical patent/BR112014018530A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A23K40/35—Making capsules specially adapted for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

AGENTES FARMACÊUTICO QUE AUMENTA A SINALIZAÇÃO SEROTONÉRGICA, USO DE UM AGONISTA DE SEROTONINA E USOS DE UM AGENTE FARMACÊUTICO QUE AUMENTA A SINALIZAÇÃO SEROTONÉRGICA. A presente revelação refere-se ao uso de agentes farmacêuticos para manipular serotonina em glândulas mamárias de animais. O uso dos agentes de serotonina resulta em níveis aumentados de PTHrP, resultando na liberação de cálcio do osso, o que aprimora a lactação.
BR112014018530A 2012-01-26 2013-01-25 Composições e métodos para aprimorar a lactação BR112014018530A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261591009P 2012-01-26 2012-01-26
PCT/US2013/023196 WO2013112873A2 (en) 2012-01-26 2013-01-25 Compositions and methods for improving lactation

Publications (2)

Publication Number Publication Date
BR112014018530A2 BR112014018530A2 (pt) 2017-06-20
BR112014018530A8 true BR112014018530A8 (pt) 2017-07-11

Family

ID=48874069

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014018530A BR112014018530A8 (pt) 2012-01-26 2013-01-25 Composições e métodos para aprimorar a lactação

Country Status (6)

Country Link
US (2) US9585870B2 (pt)
EP (1) EP2806871B1 (pt)
BR (1) BR112014018530A8 (pt)
CA (1) CA2863222C (pt)
NZ (1) NZ627895A (pt)
WO (1) WO2013112873A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106414755B (zh) 2014-05-16 2022-11-11 生物技术时代公司 用于产生5-羟基色氨酸的微生物途径

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK159807C (da) * 1989-02-27 1992-06-29 Gunnar Kjems Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvaeg, isaer ved kaelvningsfeber
US5560920A (en) * 1995-04-07 1996-10-01 The United States Of America, As Represented By The Secretary Of Agriculture Calcium formulations for prevention of parturient hypocalcemia
DE60023122T2 (de) * 1998-10-30 2006-07-13 Rj Innovation Verfahren zur Verhinderung von Hypokalzämie in gebährenden Tieren und hierfür verwendete Zusammensetzungen
WO2003013495A1 (en) * 2001-08-08 2003-02-20 Smothers Don L Formulation and method for reduction of stress in meat-producing animals
WO2003014321A2 (en) * 2001-08-10 2003-02-20 The Rockefeller University Compositions and methods for modulation of darpp-32 phosphorylation
US7241797B2 (en) * 2002-01-23 2007-07-10 University Of Cincinnati Method of increasing milk production
CA2499972A1 (en) * 2002-09-25 2004-04-08 Garvan Institute Of Medical Research Method for inducing mammary epithelial cell differentiation
US20070292493A1 (en) * 2006-06-15 2007-12-20 Brierre Barbara T Pharmaceutical composition and method for the transdermal delivery of calcium
US8133916B1 (en) * 2009-03-10 2012-03-13 Amelgo, LLC Control of milk production and mammary involution

Also Published As

Publication number Publication date
NZ627895A (en) 2015-11-27
US9585870B2 (en) 2017-03-07
WO2013112873A3 (en) 2015-06-18
EP2806871A2 (en) 2014-12-03
CA2863222C (en) 2019-01-08
WO2013112873A2 (en) 2013-08-01
US20170128418A1 (en) 2017-05-11
BR112014018530A2 (pt) 2017-06-20
US20150031741A1 (en) 2015-01-29
CA2863222A1 (en) 2013-08-01
EP2806871A4 (en) 2016-07-20
EP2806871B1 (en) 2017-03-01

Similar Documents

Publication Publication Date Title
BR112016029264A2 (pt) método para tratamento dos cabelos com um condicionador concentrado
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
CL2016002812A1 (es) Uso de ácido 3-2,3,5,6-tetrafluoro-3-trifluorometoxi-bifenil-4-ilcarbamoil-tiofeno-2-carboxílico para preparar un medicamento útil para tratar una enfermedad ocular que es uveítis, ojo seco o causada por un adenovirus composición formulación.
AR102657A1 (es) Composición para tratar telas
BR112016009874A2 (pt) Dispositivos de liberação de fármaco, e composições farmacêuticas e usos
MY176583A (en) Compositions and methods for managing or improving bone disorders, cartilage disorders, or both
CL2015003343A1 (es) Composición farmacéutica que comprende un agente terapéutico modificado en base a hemoglobina, para el tratamiento para tratar el cáncer, e imágenes de diagnóstico.
CL2014003225A1 (es) Composición que comprende un agente de control biológico y un fungicida.
DOP2016000253A (es) Nuevos compuestos
CL2018000451A1 (es) Composiciones de micropartículas que comprenden saflufenacil
BR112017004925A2 (pt) composição e método
BR112017014545A2 (pt) formulações de oxitocina que contém magnésio e métodos de uso
NZ702415A (en) Methods for treating neutropenia using retinoid agonists
BR112016013754A2 (pt) Recaptação de serotonina-norepinefrina inibidores (irsns) e combinações dos ligantes do receptor sigma
AR094851A1 (es) COMPUESTOS BICíCLICOS COMO AGONISTAS DE S1P₁
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
AR097143A1 (es) Composición alimenticia mineral para lamer para rumiantes y método para prepararla
BR112015022513A2 (pt) produto e método para tratamento de diarreia
BR112013005532A2 (pt) agente terapêutico para dor
BR112013003064A2 (pt) agente profilático ou terapêutico para a esteato-hepatite não alcoólica
BR112014018530A8 (pt) Composições e métodos para aprimorar a lactação
BR112017007863A2 (pt) composição para o tratamento de condições envolvendo dor muscular
BR112016018071A8 (pt) Composição granular inseticida e processo para a preparação da referida composição
BR112016014981A2 (pt) Acelerador de produção de catecolamina e agente preventivo e terapêutico e composição alimentícia preventiva e terapêutica para doenças causadas por deficiência de catecolamina

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL